|
ZNF649 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.899200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.495200E-01 |
| Normal-vs-Stage2 |
4.592200E-01 |
| Normal-vs-Stage3 |
3.689600E-01 |
| Normal-vs-Stage4 |
6.694300E-02 |
| Stage1-vs-Stage2 |
4.201600E-01 |
| Stage1-vs-Stage3 |
2.414400E-01 |
| Stage1-vs-Stage4 |
2.251500E-02 |
| Stage2-vs-Stage3 |
9.528800E-01 |
| Stage2-vs-Stage4 |
3.638800E-01 |
| Stage3-vs-Stage4 |
3.061400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.085600E-01 |
| Normal-vs-AfricanAmerican |
8.443400E-01 |
| Normal-vs-Asian |
2.071000E-01 |
| Caucasian-vs-AfricanAmerican |
9.587800E-01 |
| Caucasian-vs-Asian |
1.661200E-01 |
| AfricanAmerican-vs-Asian |
5.102000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.377400E-01 |
| Normal-vs-Female |
5.901200E-01 |
| Male-vs-Female |
9.994800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.680400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.151800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.134370E-01 |
| Normal-vs-Age(81-100Yrs) |
1.827170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.624200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.050300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.837640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.616240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.351200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.471200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.282430E-01 |
| Classical-VS-Follicular |
3.303900E-03 |
| Classical-VS-Other |
8.565400E-01 |
| Classical-VS-Normal |
7.545200E-01 |
| Tall-VS-Follicular |
6.522200E-01 |
| Tall-VS-Other |
5.237400E-01 |
| Tall-VS-Normal |
2.444600E-01 |
| Follicular-VS-Other |
2.751000E-01 |
| Follicular-VS-Normal |
8.589800E-02 |
| Other-VS-Normal |
7.990200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.000200E-01 |
| Normal-vs-N1 |
1.124010E-01 |
| N0-vs-N1 |
2.570600E-01 |
|
|
